The complex role of glycine N-methyltransferase in metabolism-a review
- 1 March 2025
- journal article
- review article
- Published by Springer Nature in Molecular Biology Reports
- Vol. 52 (1) , 1-15
Abstract
Background Glycine N-methyltransferase (GNMT) is an enzyme predominantly found in the liver, playing a crucial role in various metabolic pathways. GNMT is involved in transmethylation, transsulfuration, one-carbon metabolism, energy metabolism, and DNA methylation. Deletion or Knockdown of GNMT influences the expression of several key metabolic enzymes by accumulating S-adenosylmethionine (SAM). Dysregulation of GNMT and these metabolic enzymes can lead to metabolic dysfunction and chronic diseases. Objective To provide a comprehensive review of the impact of Glycine N-methyltransferase (GNMT) on metabolism, focusing on its epigenetic and genetic mechanisms, its role in metabolic pathways, and its association with chronic diseases. Results GNMT is highly expressed in the liver and exerts direct and indirect effects on various metabolic pathways, including transmethylation, transsulfuration, one-carbon metabolism, energy metabolism, and global DNA methylation. Current understanding suggests that GNMT operates through both epigenetic and genetic mechanisms, influencing the expression of key metabolic enzymes such as BHMT, NNMT, PEMT, DNMTs, CBS, and MTHFR through the accumulation of S-adenosylmethionine. Dysregulation of these proteins not only affects metabolic function but also contributes to the development of several chronic diseases. Furthermore, the level of GNMT protein has been directly linked to non-alcoholic fatty liver disease, with its function being gender, age, and organ specific. At the same time, GNMT and disease progression correlate, dietary supplementation and pharmacological approaches have shown promise in controlling GNMT levels. Conclusion GNMT plays a multifaceted role in metabolism, influencing various pathways and contributing to chronic disease development. Understanding its mechanisms and interactions opens avenues for targeted dietary and pharmacological therapies to manage GNMT-related metabolic dysfunction.Keywords
This publication has 122 references indexed in Scilit:
- Glycine N-methyltransferase−/− mice develop chronic hepatitis and glycogen storage disease in the liverHepatology, 2007
- Common genetic polymorphisms affect the human requirement for the nutrient cholineThe FASEB Journal, 2006
- A Glycine N-methyltransferase Knockout Mouse Model for Humans with Deficiency of this EnzymeTransgenic Research, 2006
- Genetic Disruption of Cytosine DNA Methyltransferase Enzymes Induces Chromosomal Instability in Human Cancer CellsCancer Research, 2005
- Modulation of Methyl Group Metabolism by Streptozotocin-induced Diabetes and All-trans-retinoic AcidJournal of Biological Chemistry, 2004
- Glycine N‐methyltransferase deficiency: A new patient with a novel mutationJournal of Inherited Metabolic Disease, 2003
- Molecular Cloning, Genomic Organization, and Mapping of PRKAG2, a Heart Abundant γ2 Subunit of 5′-AMP-Activated Protein Kinase, to Human Chromosome 7q36Genomics, 2000
- DNA Methyltransferases Dnmt3a and Dnmt3b Are Essential for De Novo Methylation and Mammalian DevelopmentCell, 1999
- Adaptation in brain glucose uptake following recurrent hypoglycemia.Proceedings of the National Academy of Sciences, 1994
- Altered methionine metabolism and transmethylation in cancer.1985